Charles Schwab Investment Management Inc Gilead Sciences, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $557 Billion
  • Q2 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 8,000,074 shares of GILD stock, worth $993 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
8,000,074
Previous 8,015,530 0.19%
Holding current value
$993 Million
Previous $898 Million 1.24%
% of portfolio
0.16%
Previous 0.17%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
SELL
$96.91 - $113.0 $1.5 Million - $1.75 Million
-15,456 Reduced 0.19%
8,000,074 $887 Million
Q1 2025

Sep 15, 2025
BUY
$89.14 - $117.41 $929,462 - $1.22 Million
10,427 Added 0.13%
8,010,501 $898 Million
Q1 2025

May 09, 2025
BUY
$89.14 - $117.41 $1.14 Million - $1.5 Million
12,751 Added 0.16%
8,015,530 $898 Million
Q4 2024

Feb 06, 2025
BUY
$83.95 - $97.9 $21 Million - $24.5 Million
249,804 Added 3.22%
8,002,779 $739 Million
Q3 2024

Nov 12, 2024
BUY
$66.59 - $83.99 $15 Million - $18.9 Million
224,960 Added 2.99%
7,752,975 $650 Million
Q2 2024

Aug 12, 2024
BUY
$63.15 - $72.88 $10.2 Million - $11.7 Million
160,755 Added 2.18%
7,528,015 $516 Million
Q1 2024

May 08, 2024
BUY
$71.58 - $87.29 $6.14 Million - $7.49 Million
85,771 Added 1.18%
7,367,260 $540 Million
Q4 2023

Feb 06, 2024
BUY
$73.27 - $83.09 $6.41 Million - $7.27 Million
87,482 Added 1.22%
7,281,489 $590 Million
Q3 2023

Nov 08, 2023
SELL
$73.94 - $80.67 $4.3 Million - $4.69 Million
-58,198 Reduced 0.8%
7,194,007 $539 Million
Q2 2023

Aug 09, 2023
SELL
$76.01 - $86.7 $11.4 Million - $13 Million
-149,444 Reduced 2.02%
7,252,205 $559 Million
Q1 2023

May 11, 2023
SELL
$77.31 - $88.08 $11.4 Million - $13 Million
-147,480 Reduced 1.95%
7,401,649 $614 Million
Q4 2022

Feb 13, 2023
BUY
$62.32 - $89.47 $7.9 Million - $11.3 Million
126,762 Added 1.71%
7,549,129 $648 Million
Q3 2022

Nov 14, 2022
BUY
$59.54 - $68.01 $18 Million - $20.5 Million
301,670 Added 4.24%
7,422,367 $458 Million
Q2 2022

Aug 15, 2022
SELL
$57.72 - $65.01 $7.55 Million - $8.5 Million
-130,735 Reduced 1.8%
7,120,697 $440 Million
Q1 2022

May 13, 2022
BUY
$57.92 - $72.58 $1.24 Million - $1.55 Million
21,422 Added 0.3%
7,251,432 $431 Million
Q4 2021

Feb 11, 2022
BUY
$64.88 - $73.64 $10.9 Million - $12.4 Million
168,674 Added 2.39%
7,230,010 $525 Million
Q3 2021

Nov 16, 2021
BUY
$67.69 - $73.03 $7.69 Million - $8.3 Million
113,605 Added 1.64%
7,061,336 $493 Million
Q2 2021

Aug 16, 2021
BUY
$63.47 - $69.35 $34.2 Million - $37.3 Million
538,153 Added 8.4%
6,947,731 $478 Million
Q1 2021

May 17, 2021
SELL
$60.0 - $68.46 $7.49 Million - $8.55 Million
-124,907 Reduced 1.91%
6,409,578 $414 Million
Q4 2020

Feb 16, 2021
BUY
$56.65 - $64.55 $1.07 Million - $1.22 Million
18,926 Added 0.29%
6,534,485 $381 Million
Q3 2020

Nov 13, 2020
SELL
$62.1 - $78.08 $24.3 Million - $30.5 Million
-390,755 Reduced 5.66%
6,515,559 $412 Million
Q2 2020

Aug 14, 2020
SELL
$72.34 - $84.0 $16 Million - $18.5 Million
-220,645 Reduced 3.1%
6,906,314 $531 Million
Q1 2020

May 15, 2020
BUY
$62.63 - $80.22 $5.79 Million - $7.42 Million
92,451 Added 1.31%
7,126,959 $533 Million
Q4 2019

Feb 07, 2020
BUY
$61.62 - $67.78 $6.81 Million - $7.5 Million
110,591 Added 1.6%
7,034,508 $457 Million
Q3 2019

Nov 08, 2019
BUY
$62.51 - $69.0 $9.08 Million - $10 Million
145,309 Added 2.14%
6,923,917 $439 Million
Q2 2019

Aug 09, 2019
BUY
$61.87 - $69.38 $8.13 Million - $9.12 Million
131,451 Added 1.98%
6,778,608 $458 Million
Q1 2019

May 14, 2019
BUY
$62.53 - $70.05 $37 Million - $41.5 Million
591,767 Added 9.77%
6,647,157 $432 Million
Q4 2018

Feb 14, 2019
BUY
$60.54 - $79.0 $14 Million - $18.3 Million
232,046 Added 3.98%
6,055,390 $379 Million
Q3 2018

Nov 13, 2018
BUY
$71.28 - $78.92 $25.4 Million - $28.1 Million
356,677 Added 6.52%
5,823,344 $450 Million
Q2 2018

Aug 08, 2018
BUY
$64.88 - $75.68 $15.7 Million - $18.3 Million
241,676 Added 4.63%
5,466,667 $387 Million
Q1 2018

May 07, 2018
BUY
$72.84 - $88.8 $4.7 Million - $5.73 Million
64,494 Added 1.25%
5,224,991 $394 Million
Q4 2017

Jan 17, 2018
BUY
$71.15 - $83.52 $14.3 Million - $16.8 Million
201,109 Added 4.06%
5,160,497 $370 Million
Q3 2017

Nov 13, 2017
BUY
$72.11 - $85.47 $358 Million - $424 Million
4,959,388
4,959,388 $402 Million

Others Institutions Holding GILD

# of Institutions
2,338
Shares Held
1.03B
Call Options Held
12.1M
Put Options Held
9.13M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $156B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email